These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2115893)

  • 1. Treatment of depersonalization with serotonin reuptake blockers.
    Hollander E; Liebowitz MR; DeCaria C; Fairbanks J; Fallon B; Klein DF
    J Clin Psychopharmacol; 1990 Jun; 10(3):200-3. PubMed ID: 2115893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment.
    Hollander E; DeCaria CM; Schneier FR; Schneier HA; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1990 Mar; 51(3):119-23. PubMed ID: 2106515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
    Servant D; Bailly D; Le Seac'h H; Parquet PJ
    Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obsessive-compulsive disorder.
    March JS; Johnston H; Greist JH
    Am Fam Physician; 1989 May; 39(5):175-82. PubMed ID: 2497627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
    McDougle CJ; Price LH; Goodman WK; Charney DS; Heninger GR
    J Clin Psychopharmacol; 1991 Jun; 11(3):175-84. PubMed ID: 1820757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL; Pigott TA
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and treatment in obsessive-compulsive disorder.
    March JS; Gutzman LD; Jefferson JW; Greist JH
    Psychiatr Dev; 1989; 7(1):1-18. PubMed ID: 2508084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypochondriasis and obsessive compulsive disorder: overlaps in diagnosis and treatment.
    Fallon BA; Javitch JA; Hollander E; Liebowitz MR
    J Clin Psychiatry; 1991 Nov; 52(11):457-60. PubMed ID: 1744062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias.
    Stein DJ; Hollander E; Anthony DT; Schneier FR; Fallon BA; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1992 Aug; 53(8):267-71. PubMed ID: 1386848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of drug treatment response in obsessive-compulsive disorder.
    Ravizza L; Barzega G; Bellino S; Bogetto F; Maina G
    J Clin Psychiatry; 1995 Aug; 56(8):368-73. PubMed ID: 7635854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of drugs in the treatment of obsessive-compulsive disorders].
    den Boer JA; Westenberg HG
    Ned Tijdschr Geneeskd; 1990 Mar; 134(10):503-4. PubMed ID: 2107405
    [No Abstract]   [Full Text] [Related]  

  • 15. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
    Perugi G; Toni C; Frare F; Travierso MC; Hantouche E; Akiskal HS
    J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.
    den Boer JA; Westenberg HG; Kamerbeek WD; Verhoeven WM; Kahn RS
    Int Clin Psychopharmacol; 1987 Jan; 2(1):21-32. PubMed ID: 3117876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obsessive compulsive disorder.
    J Clin Psychiatry; 1989 Jun; 50(6):231-2. PubMed ID: 2498297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.